Description
CNP-Arg-TMZ is an innovative drug delivery system designed to enhance the delivery of temozolomide (TMZ), a key chemotherapy drug, directly to the brain. By utilizing a cell-penetrating peptide (CNP), this platform improves the drug’s ability to cross the blood-brain barrier, increasing its effectiveness against brain tumors. CNP-Arg-TMZ aims to provide more targeted treatment with fewer side effects, offering new hope in the fight against brain cancer.
